Carrassa L - Search Results

1

Unique pattern of ET-743 activity in different cellular systems with defined deficiencies in DNA-repair pathways.

Damia G, Silvestri S, Carrassa L, Filiberti L, Faircloth GT, Liberi G, Foiani M, D'Incalci M. Damia G, et al. Among authors: carrassa l. Int J Cancer. 2001 May 15;92(4):583-8. doi: 10.1002/ijc.1221. Int J Cancer. 2001. PMID: 11304695 Free article.

2

Cisplatinum and taxol induce different patterns of p53 phosphorylation.

Damia G, Filiberti L, Vikhanskaya F, Carrassa L, Taya Y, D'incalci M, Broggini M. Damia G, et al. Among authors: carrassa l. Neoplasia. 2001 Jan-Feb;3(1):10-6. doi: 10.1038/sj.neo.7900122. Neoplasia. 2001. PMID: 11326311 Free PMC article.

3

Unique features of the mode of action of ET-743.

D'Incalci M, Erba E, Damia G, Galliera E, Carrassa L, Marchini S, Mantovani R, Tognon G, Fruscio R, Jimeno J, Faircloth GT. D'Incalci M, et al. Among authors: carrassa l. Oncologist. 2002;7(3):210-6. doi: 10.1634/theoncologist.7-3-210. Oncologist. 2002. PMID: 12065793 Free article. Review.

4

Characterization of the 5'flanking region of the human Chk1 gene: identification of E2F1 functional sites.

Carrassa L, Broggini M, Vikhanskaya F, Damia G. Carrassa L, et al. Cell Cycle. 2003 Nov-Dec;2(6):604-9. Cell Cycle. 2003. PMID: 14504477

5

Chk1, but not Chk2, is involved in the cellular response to DNA damaging agents: differential activity in cells expressing or not p53.

Carrassa L, Broggini M, Erba E, Damia G. Carrassa L, et al. Cell Cycle. 2004 Sep;3(9):1177-81. Epub 2004 Sep 13. Cell Cycle. 2004. PMID: 15326376

6

Checkpoint kinase 1 down-regulation by an inducible small interfering RNA expression system sensitized in vivo tumors to treatment with 5-fluorouracil.

Ganzinelli M, Carrassa L, Crippa F, Tavecchio M, Broggini M, Damia G. Ganzinelli M, et al. Among authors: carrassa l. Clin Cancer Res. 2008 Aug 15;14(16):5131-41. doi: 10.1158/1078-0432.CCR-08-0304. Clin Cancer Res. 2008. PMID: 18698031

7

U2OS cells lacking Chk1 undergo aberrant mitosis and fail to activate the spindle checkpoint.

Carrassa L, Sanchez Y, Erba E, Damia G. Carrassa L, et al. J Cell Mol Med. 2009 Aug;13(8A):1565-76. doi: 10.1111/j.1582-4934.2009.00362.x. J Cell Mol Med. 2009. PMID: 19778378 Free PMC article.

8

Role of Chk1 in the differentiation program of hematopoietic stem cells.

Carrassa L, Montelatici E, Lazzari L, Zangrossi S, Simone M, Broggini M, Damia G. Carrassa L, et al. Cell Mol Life Sci. 2010 May;67(10):1713-22. doi: 10.1007/s00018-010-0274-1. Epub 2010 Feb 10. Cell Mol Life Sci. 2010. PMID: 20146081 Free PMC article.

9

Unleashing Chk1 in cancer therapy.

Carrassa L, Damia G. Carrassa L, et al. Cell Cycle. 2011 Jul 1;10(13):2121-8. doi: 10.4161/cc.10.13.16398. Epub 2011 Jul 1. Cell Cycle. 2011. PMID: 21610326 Review.

10

Combined inhibition of Chk1 and Wee1: in vitro synergistic effect translates to tumor growth inhibition in vivo.

Carrassa L, Chilà R, Lupi M, Ricci F, Celenza C, Mazzoletti M, Broggini M, Damia G. Carrassa L, et al. Cell Cycle. 2012 Jul 1;11(13):2507-17. doi: 10.4161/cc.20899. Epub 2012 Jul 1. Cell Cycle. 2012. PMID: 22713237

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters